Abstract
Background: We report our 10-year experience of performing surgical resection of T4 lung cancer invading the thoracic aorta. Patients and Methods: From 1994 to 2004, sixteen patients with T4 primary lung cancer with local invasion of the thoracic aorta underwent tumor resection. Surgical resection included 8 pneumonectomies and 8 lobectomies. The histologic type was squamous cell carcinoma in 7 patients, adenocarcinoma in 7, large cell carcinoma in 1, and small cell carcinoma in 1. Complete resection of the tumor with mediastinal lymph node dissection was achieved in 8 patients (50 %), while the resection was incomplete in the other 8 cases. Results: The overall cumulative survival of the 16 patients at 3 and 5 years was 34.7 % and 17.4 %, respectively. The survival of the patients in the complete resection group was found to be 36.5 % at 5 years, with 2 patients surviving more than 5 years without a recurrence, which was significantly better than that of the incomplete resection group (p = 0.005). Conclusions: Extended aortic resection with primary lung cancer is complex and possibly high risk, but can achieve long-term survival in selected patients. Surgical resection should be considered as a treatment option for T4 lung cancer for this T4 subcategory.
Key words
Lung cancer - T4 - aorta - cardiopulmonary support - prognosis
References
-
1
Naruke T, Goya T, Tsuchiya R, Suemasu K.
Prognosis and survival in resected lung carcinoma based on the new international staging system.
J Thorac Cardiovasc Surg.
1988;
96
440-447
-
2
Ginsberg R J.
Limits and perspectives of surgical resection for non-small cell lung cancer.
Lung Cancer.
1991;
7
35-39
-
3
Macchiarini P, Chapelier A R, Monnet I, Vannetzel J M, Rebischung J L, Cerrina J, Parquin F, Ladurie F L, Lenot B, Dartevelle P G.
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer.
Ann Thorac Surg.
1994;
57
966-973
-
4
Faber L P, Kittle C F, Warren W H, Bonomi P D, Taylor 4th S G.
Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer.
Ann Thorac Surg.
1989;
47
669-675
-
5
Rendina E A, Venuta F, De Giacomo T, Ciccone A M, Ruvolo G, Coloni G F, Ricci C.
Induction chemotherapy for T4 centrally located non-small cell lung cancer.
J Thorac Cardiovasc Surg.
1999;
117
225-233
-
6
Mountain C F.
Revisions in the international system for staging lung cancer.
Chest.
1997;
111
1710-1717
-
7
Martini N, Yellin A, Ginsberg R J, Bains M S, Burt M E, McCormack P M, Rusch V W.
Management of non-small cell lung cancer with direct mediastinal involvement.
Ann Thorac Surg.
1994;
58
1447-1451
-
8
Burt M E, Pomerantz A H, Bains M S, McCormack P M, Kaiser L R, Hilaris B S, Martini N.
Results of surgical treatment of stage III lung cancer invading the mediastinum.
Surg Clin North Am.
1987;
67
987-1000
-
9
Rusch V W, Albain K S, Crowley J J, Rice T W, Lonchyna V, McKenna Jr R, Stelzer K, Livingston R B.
Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group.
Ann Thorac Surg.
1994;
58
290-294
-
10
Katakami N, Okazaki M, Nishiuchi S, Fukuda H, Horikawa T, Nishiyama H, Inui H, Bando K.
Induction chemoradiotherapy for advanced stage III non-small cell lung cancer: long-term follow-up in 42 patients.
Lung Cancer.
1998;
22
127-137
-
11
Fukuse T, Wada H, Hitomi S.
Extended operation for non-small cell lung cancer invading great vessels and left atrium.
Eur J Cardiothorac Surg.
1997;
11
664-669
-
12
Mitchell J D, Mathisen D J, Wright C D, Wain J C, Donahue D M, Allan J S, Moncure A C, Grillo H C.
Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.
J Thorac Cardiovasc Surg.
2001;
121
465-471
-
13
Spaggiari L, Regnard J F, Magdeleinat P, Jauffret B, Puyo P, Levasseur P.
Extended resections for bronchogenic carcinoma invading the superior vena cava system.
Ann Thorac Surg.
2000;
69
233-236
-
14
Naruke T, Goya T, Tsuchiya R, Suemasu K.
The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis.
Ann Thorac Surg.
1988;
46
603-610
-
15
Stamatis G, Eberhardt W, Stuben G, Bildat S, Dahler O, Hillejan L.
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results.
Ann Thorac Surg.
1999;
68
1144-1149
-
16
Rice T W, Blackstone E H.
Radical resection for T4 lung cancer.
Surg Clin North Am.
2002;
82
573-587
-
17
Izbicki J R, Knoefel W T, Passlick B, Habekost M, Karg O, Thetter O.
Risk analysis and long-term survival in patients undergoing extended resection of locally advanced lung cancer.
J Thorac Cardiovasc Surg.
1995;
110
386-395
-
18
Klepetko W, Wisser W, Birsan T, Mares P, Taghavi S, Kupilik N, Wolner E.
T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable?.
Ann Thorac Surg.
1999;
67
340-344
-
19
Tsuchiya R, Asamura H, Kondo H, Goya T, Naruke T.
Extended resection of the left atrium, great vessels, or both for lung cancer.
Ann Thorac Surg.
1994;
57
960-965
-
20
Pitz C C, Brutel de la Riviere A, van Swieten H A, Westermann C J, Lammers J W, van den Bosch J M.
Results of surgical treatment of T4 non-small cell lung cancer.
Eur J Cardiothorac Surg.
2003;
24
1013-1018
-
21
Bernard A, Bouchot O, Hagry O, Favre J P.
Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer.
Eur J Cardiothorac Surg.
2001;
20
344-349
MD Takeshi Shiraishi
Department of Surgery II, Fukuoka University School of Medicine
7-45-1 Nanakuma Jonan-ku
Fukuoka City, Fukuoka
814-0180, Japan
Phone: + 81928011011
Fax: + 81 9 28 61 82 71
Email: tshiraishi-ths@umin.ac.jp